Advertisement

Pharmacy

Teva Pharmaceuticals, the world's largest generic drugmaker, saw its second-quarter revenue decline 18 percent to $4.7 billion — suggesting its financial woes have not passed, The Wall Street Journal reports.

AuroMedics Pharma has issued a nationwide recall of two lots of injectable Piperacillin and Tazobactam, a penicillin antibiotic used to treat pelvic infections, skin infections and hospital-acquired pneumonia.

Ian Read, Pfizer's CEO, believes the controversial rebates drugmakers pay to pharmacy benefit managers will soon vanish, according to STAT.

Advertisement

AstraZeneca will not raise the price of its medications in 2018, joining the ranks of numerous drug companies changing their pricing strategies after scrutiny from President Donald Trump, reports Reuters. 

Advertisement